Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
All content for Ordinary Unhappiness is the property of Patrick & Abby and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
105: Standard Edition Volume 2 Part 3: Studies on Hysteria, Part III: Four Versions of Anna O. Teaser
Ordinary Unhappiness
5 minutes
5 months ago
105: Standard Edition Volume 2 Part 3: Studies on Hysteria, Part III: Four Versions of Anna O. Teaser
Subscribe to get access to the full episode, the episode reading list, and all premium episodes! www.patreon.com/OrdinaryUnhappiness Abby, Patrick, and Dan return to the first case study in Studies On Hysteria (1895). But while previously they examined the case of “Anna O.” as told narrowly by Josef Breuer on his own terms, this time they tell the story of the remarkable woman behind it: Bertha Pappenheim. They begin by addressing how the legend of a “hysterical pregnancy” came to overshadow ...
Ordinary Unhappiness
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
